Manufactured shoes in the prevention of diabetic foot ulcers
Manufactured shoes in the prevention of diabetic foot ulcers. L Uccioli , E Faglia , G Monticone , F Favales , L Durola , A Aldeghi , A Quarantiello , P Calia and G Menzinger Cattedra di Endocrinologia, Università Tor Vergata, Rome, Italy. Abstract OBJECTIVE: To evaluate the efficacy of manufactured...
Saved in:
Published in: | Diabetes care Vol. 18; no. 10; pp. 1376 - 1378 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Alexandria, VA
American Diabetes Association
01-10-1995
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Manufactured shoes in the prevention of diabetic foot ulcers.
L Uccioli ,
E Faglia ,
G Monticone ,
F Favales ,
L Durola ,
A Aldeghi ,
A Quarantiello ,
P Calia and
G Menzinger
Cattedra di Endocrinologia, Università Tor Vergata, Rome, Italy.
Abstract
OBJECTIVE: To evaluate the efficacy of manufactured shoes specially designed for diabetic patients (Podiabetes by Buratto
Italy) to prevent relapses of foot ulcerations. RESEARCH DESIGN AND METHODS: A prospective multicenter randomized follow-up
study of patients with previous foot ulcerations was conducted. Patients were alternatively assigned to wear either their
own shoes (control group, C; n = 36) or therapeutic shoes (Podiabetes group, P; n = 33). The number of ulcer relapses was
recorded during 1-year follow-up. RESULTS: Both C and P groups had similar risk factors for foot ulceration (i.e., previous
foot ulceration, mean vibratory perception threshold > 25 mV). After 1 year, the foot ulcer relapses were significantly lower
in P than in C (27.7 vs. 58.3%; P = 0.009; odds ratio 0.26 [0.2-1.54]). In a multiple regression analysis, the use of therapeutic
shoes was negatively associated with foot ulcer relapses (coefficient of variation = -0.315; 95% confidence interval = -0.54
to -0.08; P = 0.009). CONCLUSIONS: The use of specially designed shoes is effective in preventing relapses in diabetic patients
with previous ulceration. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-News-3 content type line 23 |
ISSN: | 0149-5992 1935-5548 |
DOI: | 10.2337/diacare.18.10.1376 |